Baylor, Scott & White Research Institute

Dallas, Texas 75246

22 studies enrolling now · 59 studies all time

What they study most

ATTR Amyloidosis With Cardiomyopathy, Acute GVHD, Acute Myeloid Leukemia, Acute Respiratory Failure, Acute-graft-versus-host Disease, Advanced Solid Tumors, Alzheimer Disease, Aortic Insufficiency, Aortic Regurgitation, Aortic Valve Disease, Aortic Valve Insufficiency, Astrocytoma, Grade III

Studies at this site

• A Study to Test Whether BI 3802876 is Tolerated in People With Compensated Liver Cirrhosis Due to Metabolic Dysfunction- Associated Steatohepatitis (MASH) — Recruiting now
• EncompaSSc: Evaluation of MTX-474 in Participants With Diffuse Cutaneous Systemic Sclerosis (dcSSc) — Recruiting now
• STRIVE Post-Market Registry Study — Recruiting now
• A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations — Recruiting now
• A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma — Recruiting now
• Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias — Recruiting now
• BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT — Recruiting now
• A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM) — Recruiting now
• Study of the Kono-S Anastomosis Versus the Side-to-side Functional End Anastomosis — Recruiting now
• IMPRoving Outcomes in Vascular DisEase - Aortic Dissection — Recruiting now
• Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women — Recruiting now
• MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM) — Recruiting now
• Multi-Center Registry for Peripheral Arterial Disease Interventions and Outcomes — Recruiting now
• Bio-Banking of Specimens for Advanced Lung Disease and Lung Transplant Research — Recruiting now
• Minimally Invasive Molecular Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Adenocarcinoma — Recruiting now
• Efficacy of a Telehealth Delivered Group Lifestyle Balance for People Post Stroke (tGLB-CVA) — Recruiting now
• Observational, Non-Interventional Study Supporting Validation of VO2Max Estimation Methods Using Results in Patients Receiving Standard of Care Cardiopulmonary Exercise Tests (CPET) — Recruiting now
• Validation of Donor-Derived Cell-Free DNA (Dd-cfDNA) for Kidney Transplant Monitoring — Recruiting now
• US National TOP Registry — Recruiting now
• INSPIRE Pipeline™ Shield Post Approval Study — Running, not enrolling
• Study of APX-115 in Contrast Induced Acute Kidney Injury in Subjects Undergoing PCI — Completed
• Real-World Experience - Barostim™ Advancing the Level of Clinical Evidence (REBALANCE Registry) — Stopped early
• Topical Antibiotic Therapy to Reduce Infection After Operative Treatment of Fractures at High Risk of Infection: TOBRA — Completed
• Clinical Trial to Evaluate the Safety and Efficacy of DWN12088 in Patients With IPF — Running, not enrolling
• A Trial to Evaluate Efficacy and Safety of Buloxibutid in People With Idiopathic Pulmonary Fibrosis. — Running, not enrolling
• Hyperangulated Versus Standard Geometry Laryngoscope Blade Trial — Enrolling by invitation
• Ultrafiltration Versus IV Diuretics in Worsening Heart Failure — Stopped early
• Scale-Up Evaluation Trial of the Diabetes Prevention Program to Improve Obesity and Cardiometabolic Health After Traumatic Brain Injury — Starting soon
• Clinical Evaluation of the AccuCinch® Ventricular Restoration System in Patients Who Present With Symptomatic Heart Failure With Reduced Ejection Fraction (HFrEF): The CORCINCH-HF Study — Paused
• A Study to Investigate the Safety, Tolerability, PK, PD, and Efficacy of ONO-7018 in Patients With R/R NHL or CLL — Stopped early
• MagnetisMM-3: Study Of Elranatamab (PF-06863135) Monotherapy in Participants With Multiple Myeloma Who Are Refractory to at Least One PI, One IMiD and One Anti-CD38 mAb — Running, not enrolling
• P-CD19CD20-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With B Cell Malignancies — Running, not enrolling
• Endovascular Engineering ENGULF Study — Completed
• Long-term Follow-up Study of Allogeneic Gamma Delta (γδ) CAR T Cells — Running, not enrolling
• A Study of CD19 Targeted CAR T Cell Therapy in Adult Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukaemia (ALL) — Running, not enrolling
• Phase 1 Study of Shattuck Labs (SL)-172154 in Subjects With MDS or AML — Stopped early
• An Observational Study of Patients With Chronic Liver Disease — Enrolling by invitation
• Expanded Access Program for OOS Obe-cel — Available (expanded access)
• Management of Antiplatelet Regimen During Surgical Procedures — Completed
• LYT-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF) — Running, not enrolling
• Evaluate the Efficacy & Safety of Leronlimab in Patients With Severe or Critical COVID-19 — Completed
• Expanding Delivery of an Evidence-based Weight-loss Intervention to Enhance Access and Reach Underserved Groups After TBI — Running, not enrolling
• OCS™ Lung TOP Registry For Donor Lungs for Transplantation — Running, not enrolling
• A Study of Itolizumab in Combination With Corticosteroids for the First-Line Treatment of Acute Graft Versus Host Disease (EQUATOR) — Stopped early
• Simufilam 100 mg for Mild-to-Moderate Alzheimer's Disease — Completed
• Open-label Extension for Phase 3 Clinical Trials of Simufilam — Stopped early
• Global Utilization And Registry Database for Improved preservAtion of doNor LUNGs — Enrolling by invitation
• Case-Control Study of the Glycotest™ HCC Panel Vs AFP for the Detection of Early-stage Hepatocellular Carcinoma — Running, not enrolling
• Expanded Access Protocol to Provide Patisiran to Patients With Transthyretin-mediated Amyloidosis With Cardiomyopathy — NO_LONGER_AVAILABLE
• Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer — Completed